Literature DB >> 24407288

The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.

Eric Haines1, Caroline Saucier, Audrey Claing.   

Abstract

Signals downstream of growth factor receptors play an important role in mammary carcinogenesis. Recently, we demonstrated that the small GTPases ARF1 and ARF6 were shown to be activated downstream of the epidermal growth factor receptor (EGFR) and act as a key regulator of growth, migration, and invasion of breast cancer cells. However, the mechanism via which the EGFR recruits and activates ARF1 and ARF6 to transmit signals has yet to be fully elucidated. Here, we identify adaptor proteins Grb2 and p66Shc as important regulators mediating ARF activation. We demonstrate that ARF1 can be found in complex with Grb2 and p66Shc upon EGF stimulation of the basal-like breast cancer MDA-MB-231 cell line. However, we report that these two adaptors regulate ARF1 activation differently, with Grb2 promoting ARF1 activation and p66Shc blocking this response. Furthermore, we show that Grb2 is essential for the recruitment of ARF1 to the EGFR, whereas p66Shc hindered ARF1 receptor recruitment. We demonstrate that the negative regulatory role of p66Shc stemmed from its ability to block the recruitment of Grb2/ARF1 to the EGFR. Conversely, p66Shc potentiates ARF6 activation as well as the recruitment of this ARF isoform to the EGFR. Interestingly, we demonstrate that Grb2 is also required for the activation and receptor recruitment of ARF6. Additionally, we show an important role for p66Shc in modulating ARF activation, cell growth, and migration in HER2-positive breast cancer cells. Together, our results highlight a central role for adaptor proteins p66Shc and Grb2 in the regulation of ARF1 and ARF6 activation in invasive breast cancer cells.

Entities:  

Keywords:  ARF; Adaptor Proteins; Breast Cancer; Epidermal Growth Factor Receptor (EGFR); GTPase

Mesh:

Substances:

Year:  2014        PMID: 24407288      PMCID: PMC3937643          DOI: 10.1074/jbc.M113.516047

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

Review 1.  ARF proteins: roles in membrane traffic and beyond.

Authors:  Crislyn D'Souza-Schorey; Philippe Chavrier
Journal:  Nat Rev Mol Cell Biol       Date:  2006-05       Impact factor: 94.444

2.  Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.

Authors:  Suresh Veeramani; Tsukasa Igawa; Ta-Chun Yuan; Fen-Fen Lin; Ming-Shyue Lee; Jamie S Lin; Sonny L Johansson; Ming-Fong Lin
Journal:  Oncogene       Date:  2005-11-03       Impact factor: 9.867

Review 3.  EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization.

Authors:  Hui-Wen Lo; Sheng-Chieh Hsu; Mien-Chie Hung
Journal:  Breast Cancer Res Treat       Date:  2006-02       Impact factor: 4.872

4.  ARF6 activation by Galpha q signaling: Galpha q forms molecular complexes with ARNO and ARF6.

Authors:  Patrick Giguère; Moulay Driss Rochdi; Geneviève Laroche; Emilie Dupré; Matthew R Whorton; Roger K Sunahara; Audrey Claing; Gilles Dupuis; Jean-Luc Parent
Journal:  Cell Signal       Date:  2006-03-14       Impact factor: 4.315

5.  The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis.

Authors:  Elena Beltrami; Silvia Valtorta; Rosamaria Moresco; Raluca Marcu; Sara Belloli; Ambrogio Fassina; Ferruccio Fazio; Piergiuseppe Pelicci; Marco Giorgio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.

Authors:  Sebastian Lewis-Saravalli; Shirley Campbell; Audrey Claing
Journal:  Cell Signal       Date:  2013-05-23       Impact factor: 4.315

7.  P66Shc-rac1 pathway-mediated ROS production and cell migration is downregulated by ascorbic acid.

Authors:  Deeba Kirmani; Hina F Bhat; Muneesa Bashir; Mohammad A Zargar; Firdous A Khanday
Journal:  J Recept Signal Transduct Res       Date:  2013-03-06       Impact factor: 2.092

8.  Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.

Authors:  Suresh Veeramani; Yu-Wei Chou; Frank C Lin; Sakthivel Muniyan; Fen-Fen Lin; Satyendra Kumar; Yan Xie; Subodh M Lele; Yaping Tu; Ming-Fong Lin
Journal:  Free Radic Biol Med       Date:  2012-04-16       Impact factor: 7.376

9.  Diallyl trisulfide-induced prostate cancer cell death is associated with Akt/PKB dephosphorylation mediated by P-p66shc.

Authors:  Andzelika Borkowska; Alicja Sielicka-Dudzin; Anna Herman-Antosiewicz; Michal Wozniak; Donatella Fedeli; Giancarlo Falcioni; Jedrzej Antosiewicz
Journal:  Eur J Nutr       Date:  2011-10-22       Impact factor: 5.614

10.  Phosphotyrosine interactome of the ErbB-receptor kinase family.

Authors:  Waltraud X Schulze; Lei Deng; Matthias Mann
Journal:  Mol Syst Biol       Date:  2005-05-25       Impact factor: 11.429

View more
  21 in total

1.  Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.

Authors:  Concha López-Ginés; Lara Navarro; Lisandra Muñoz-Hidalgo; Enrique Buso; José Manuel Morales; Rosario Gil-Benso; Mariela Gregori-Romero; Javier Megías; Pedro Roldán; Remedios Segura-Sabater; José Manuel Almerich-Silla; Daniel Monleón; Miguel Cerdá-Nicolás
Journal:  Cell Oncol (Dordr)       Date:  2017-06-19       Impact factor: 6.730

2.  The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.

Authors:  Eric Haines; Sabrina Schlienger; Audrey Claing
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

Review 3.  Steering cell migration: lamellipodium dynamics and the regulation of directional persistence.

Authors:  Matthias Krause; Alexis Gautreau
Journal:  Nat Rev Mol Cell Biol       Date:  2014-09       Impact factor: 94.444

4.  GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasion.

Authors:  Mathieu J F Crupi; Sarah M Maritan; Eduardo Reyes-Alvarez; Eric Y Lian; Brandy D Hyndman; Aisha N Rekab; Serisha Moodley; Costin N Antonescu; Lois M Mulligan
Journal:  Oncogene       Date:  2019-10-23       Impact factor: 9.867

5.  The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients.

Authors:  Ajay Chatrath; Manjari Kiran; Pankaj Kumar; Aakrosh Ratan; Anindya Dutta
Journal:  Mol Cancer Res       Date:  2019-01-16       Impact factor: 5.852

6.  Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Li-Yan Li; En-Min Li; Zhi-Yong Wu; Hui-Hui Cao; Jin-Hui Shen; Xiu-E Xu; Bo Chen; Jian-Yi Wu; Li-Yan Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

7.  Adaptor Protein p66Shc: A Link Between Cytosolic and Mitochondrial Dysfunction in the Development of Diabetic Retinopathy.

Authors:  Manish Mishra; Arul J Duraisamy; Sudarshan Bhattacharjee; Renu A Kowluru
Journal:  Antioxid Redox Signal       Date:  2018-10-03       Impact factor: 8.401

Review 8.  p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis.

Authors:  Sahar S Bhat; Deepak Anand; Firdous A Khanday
Journal:  Mol Cancer       Date:  2015-04-08       Impact factor: 27.401

9.  Ras, TrkB, and ShcA Protein Expression Patterns in Pediatric Brain Tumors.

Authors:  Monika Prill; Agnieszka Karkucinska-Wieckowska; Magdalena Lebiedzinska-Arciszewska; Giampaolo Morciano; Agata Charzynska; Michal Dabrowski; Maciej Pronicki; Paolo Pinton; Wieslawa Grajkowska; Mariusz R Wieckowski
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

10.  11-epi-Sinulariolide acetate reduces cell migration and invasion of human hepatocellular carcinoma by reducing the activation of ERK1/2, p38MAPK and FAK/PI3K/AKT/mTOR signaling pathways.

Authors:  Jen-Jie Lin; Jui-Hsin Su; Chi-Chu Tsai; Yi-Jen Chen; Ming-Hui Liao; Yu-Jen Wu
Journal:  Mar Drugs       Date:  2014-09-12       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.